** Shares of medical equipment maker Revvity RVTY.N gain
6% to $122 premarket
** Co raises FY24 adj. EPS forecast to the range of
$4.7-$4.8, up from earlier expectation of $4.55-$4.75
** Analysts expect an average of $4.63 per share - LSEG data
** RVTY sees annual revenue in the range of $2.77 bln to
$2.79 bln vs prior est. of $2.76 bln to $2.82 bln
** Co's Q2 results beat Wall Street estimates
** Reports 3% YoY increase in its diagnostic unit's Q2
organic revenue
** Twelve brokerages rate RVTY "buy" or higher, while eight
rate it "hold"; their median PT is $125 - LSEG data
** As of last close, stock up more than 5% YTD
(Reporting by Purvi Agarwal in Bengaluru)
((Purvi.Agarwal@thomsonreuters.com))